AbbVie Inc
(TSX:ABBV)
C$
35.51
-1.4 (-3.79%)
Market Cap: 592.81 Bil
Enterprise Value: 683.00 Bil
PE Ratio: 123.73
PB Ratio: 0
GF Score: 81/100 Abbvie Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 20, 2020 / 02:50PM GMT
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Hello, and welcome to day 3 of the UBS Healthcare Conference. My name is Navin Jacob, senior analyst covering large-cap pharmaceuticals and smid-cap biotech. Our next presentation and fireside chat is with AbbVie. I'm very happy to have with me Mike Severino, Vice Chairman and President of AbbVie; as well as Rob Michael, CFO of AbbVie; as well as Liz Shea, Head of Investor Relations. Thank you all for joining us today.
Robert A. Michael
AbbVie Inc. - Executive VP & CFO
Thanks for having us.
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Pleasure.
Questions & Answers
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
We are just going to
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot